Home > Insider Trading > Filing (0001022079-23-000070)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222679	E Michael Prevoznik	500 Plaza Drive Secaucus NJ 07094	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-03-06	8,595	$147.86	47,122	No	4	A	Direct
Common Stock	Disposition	2023-03-06	3,841	$147.86	43,281	No	4	F	Direct
Common Stock	Disposition	2023-03-07	4,754	$140.55	38,527	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,412	Indirect	401(k)/SDCP

Footnotes

Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 27, 2022.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.